Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Nekoee Zahraei (Liege, Belgium), F. Schleich (Liege, Belgium), E. Graulich (Liege, Belgium), M. Henket (Liege, Belgium), V. Paulus (Liege, Belgium), F. Guissard (Liege, Belgium), A. Donneau (Liege, Belgium), R. Louis (Liege, Belgium). Are T2 biomarkers of any help in diagnosing asthma?. 2204

Member's Comments

No comment yet.

Related content which might interest you: The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm Source: Eur Respir J, 59 (2) 2102669; 10.1183/13993003.02669-2021 Year: 2022 Do measures of bronchial responsiveness add information in diagnosis and monitoring of patients with asthma? Source: Eur Respir J 2001; 18: 439-441 Year: 2001 Is the S-ECP/Eo ratio of any benefit for diferential diagnosis of early childhood bronchial asthma? Source: Eur Respir J 2004; 24: Suppl. 48, 612s Year: 2004 Is spirometry screening useful for detecting undiagnosed COPD? Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011 The challenge of getting the right diagnosis: asthma and COPD, new diagnostic possibilities Source: International Congress 2016 – Primary Care Day: challenging times I Year: 2016 Can YKL-40 be used as a biomarker and therapeutic target for adult asthma? Source: Eur Respir J, 51 (1) 1702194; 10.1183/13993003.02194-2017 Year: 2018 Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma Source: Eur Respir J 2006; 28: Suppl. 50, 122s Year: 2006 The role of biomarkers in the management of severe asthma Source: International Congress 2019 – Severe asthma guidelines: update 2019 Year: 2019 What new biomarkers are on the horizon for severe exacerbations? Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 What is the best biomarker of COVID-19 pneumonia progression? Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 eNose breathprints as surrogate biomarkers for classifying asthma patients by atopy Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 COPD: implementing biomarkers to improve prognosis Source: Virtual Congress 2021 – Clinical year in review Year: 2021 Can telemedicine help in SDB diagnosis? Source: Sleep and Breathing Conference 2017 Year: 2017 Application of biomarkers and patient characteristics to personalize asthma treatment for children Source: International Congress 2016 – Deep phenotyping to improve treatment outcomes in paediatric asthma Year: 2016